Literature DB >> 18253757

Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: report of three Turkish siblings.

Harun Peru1, Fatih Akin, Sefika Elmas, Ahmet Midhat Elmaci, Martin Konrad.   

Abstract

Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), an autosomal recessive renal tubular disorder is characterized by the impaired tubular reabsorption of magnesium and calcium in the thick ascending limb of the loop of Henle. This disease is caused by mutations in the claudin-16 gene (CLDN16), which encodes the tight junction protein, claudin-16. Claudin-16 belongs to the claudin family and regulates the paracellular transport of magnesium and calcium. Here, we report on three Turkish siblings with typical clinical features of FHHNC in association with the homozygous mutation Leu151Phe.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253757     DOI: 10.1007/s00467-008-0758-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

Review 1.  Should dietary calcium and protein be restricted in patients with nephrolithiasis?

Authors:  L A Martini; R J Wood
Journal:  Nutr Rev       Date:  2000-04       Impact factor: 7.110

Review 2.  Hypomagnesaemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review.

Authors:  V Benigno; C S Canonica; A Bettinelli; R O von Vigier; A C Truttmann; M G Bianchetti
Journal:  Nephrol Dial Transplant       Date:  2000-05       Impact factor: 5.992

3.  [Early hypomagnesemia, hypercalciuria and nephrocalcinosis: two cases in a family].

Authors:  C Mourani; E Khallouf; V Akkari; C Akatcherian; P Cochat
Journal:  Arch Pediatr       Date:  1999-07       Impact factor: 1.180

4.  Familial hypomagnesemia-hypercalciuria in 2 siblings.

Authors:  E Kuwertz-Bröking; S Fründ; M Bulla; R Kleta; C August; K Kisters
Journal:  Clin Nephrol       Date:  2001-08       Impact factor: 0.975

5.  Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement.

Authors:  Martin Konrad; Andre Schaller; Dominik Seelow; Amit V Pandey; Siegfried Waldegger; Annegret Lesslauer; Helga Vitzthum; Yoshiro Suzuki; John M Luk; Christian Becker; Karl P Schlingmann; Marcel Schmid; Juan Rodriguez-Soriano; Gema Ariceta; Francisco Cano; Ricardo Enriquez; Harald Juppner; Sevcan A Bakkaloglu; Matthias A Hediger; Sabina Gallati; Stephan C F Neuhauss; Peter Nurnberg; Stefanie Weber
Journal:  Am J Hum Genet       Date:  2006-09-19       Impact factor: 11.025

6.  [Familial hypomagnesemia with hypercalciuria and nephrocalcinosis].

Authors:  M Martín Aguado; A Canals Baeza; L Sanguino López; C Gavilán Martín; J Flores Serrano
Journal:  An Esp Pediatr       Date:  2001-02

7.  The congenital "magnesium-losing kidney". Report of two patients.

Authors:  R A Evans; J N Carter; C R George; R S Walls; R C Newland; G D McDonnell; J R Lawrence
Journal:  Q J Med       Date:  1981

8.  Two heterozygous mutations of CLDN16 in a Japanese patient with FHHNC.

Authors:  Toshihiro Tajima; Jun Nakae; Kenji Fujieda
Journal:  Pediatr Nephrol       Date:  2003-10-30       Impact factor: 3.714

9.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  M Praga; J Vara; E González-Parra; A Andrés; C Alamo; A Araque; A Ortiz; J L Rodicio
Journal:  Kidney Int       Date:  1995-05       Impact factor: 10.612

10.  Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption.

Authors:  D B Simon; Y Lu; K A Choate; H Velazquez; E Al-Sabban; M Praga; G Casari; A Bettinelli; G Colussi; J Rodriguez-Soriano; D McCredie; D Milford; S Sanjad; R P Lifton
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

View more
  1 in total

1.  Bilateral slipped capital femoral epiphysis in a male adolescent with familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), chronic renal failure, and severe hyperparathyroidism.

Authors:  Przemysław Sikora; Małgorzata Zajączkowska; Tomasz Raganowicz; Halina Borzęcka; Andrzej Gregosiewicz; Martin Konrad
Journal:  Eur J Pediatr       Date:  2013-03-03       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.